Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Cash from Operations (Quarterly): 826.50M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 826.50M |
June 30, 2024 | 379.10M |
March 31, 2024 | 614.60M |
December 31, 2023 | 468.10M |
September 30, 2023 | 835.20M |
June 30, 2023 | 525.10M |
March 31, 2023 | 971.20M |
December 31, 2022 | 142.60M |
September 30, 2022 | 869.00M |
June 30, 2022 | 802.50M |
March 31, 2022 | 1.138B |
December 31, 2021 | 523.10M |
September 30, 2021 | 1.086B |
June 30, 2021 | 559.40M |
March 31, 2021 | 848.80M |
December 31, 2020 | 36.20M |
September 30, 2020 | 525.00M |
June 30, 2020 | 379.50M |
March 31, 2020 | 291.10M |
December 31, 2019 | 686.70M |
September 30, 2019 | 487.80M |
June 30, 2019 | 668.90M |
March 31, 2019 | -39.70M |
December 31, 2018 | 636.10M |
September 30, 2018 | 653.60M |
Date | Value |
---|---|
June 30, 2018 | 430.20M |
March 31, 2018 | 621.80M |
December 31, 2017 | 495.50M |
September 30, 2017 | 548.60M |
June 30, 2017 | 567.80M |
March 31, 2017 | 452.90M |
December 31, 2016 | 349.50M |
September 30, 2016 | 1.201B |
June 30, 2016 | 416.60M |
March 31, 2016 | 80.50M |
December 31, 2015 | 652.00M |
September 30, 2015 | 974.80M |
June 30, 2015 | 114.70M |
March 31, 2015 | 267.00M |
December 31, 2014 | 126.60M |
September 30, 2014 | 440.70M |
June 30, 2014 | 179.40M |
March 31, 2014 | 268.10M |
December 31, 2013 | 417.90M |
September 30, 2013 | 414.70M |
June 30, 2013 | 186.40M |
March 31, 2013 | 87.60M |
December 31, 2012 | 291.04M |
September 30, 2012 | 462.37M |
June 30, 2012 | 302.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
36.20M
Minimum
Dec 2020
1.138B
Maximum
Mar 2022
625.39M
Average
587.00M
Median
Cash from Operations (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | -53.62M |
Moderna Inc | -1.566B |
Baxter International Inc | 253.00M |
Gilead Sciences Inc | 4.309B |
Perspective Therapeutics Inc | 3.366M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 1.748B |
Cash from Financing (Quarterly) | -1.637B |
Free Cash Flow | 1.893B |
Free Cash Flow Per Share (Quarterly) | 0.6174 |
Free Cash Flow to Equity (Quarterly) | 2.090B |
Free Cash Flow to Firm (Quarterly) | 893.62M |
Free Cash Flow Yield | 11.77% |